THOMAS BUZBEE: Open Payments
NPI 1770682619 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,885 in 116 payments from 17 companies in 2025. Trend: 2023 $12,486 · 2024 $21,261 · 2025 $15,885
Speaker / faculty: $14,000Food & beverage: $1,716Travel & lodging: $146Education: $24
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 32 | $14,786 |
| Novo Nordisk Inc | 21 | $241 |
| PFIZER INC. | 19 | $180 |
| ABBVIE INC. | 23 | $175 |
| Novartis Pharmaceuticals Corporation | 6 | $98 |
| Hologic Sales and Service, LLC | 1 | $93 |
| Corcept Therapeutics | 2 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Bioventus LLC | 1 | $26 |
| Boston Scientific Corporation | 1 | $25 |
Products named: REPATHA, NURTEC ODT, LEQVIO, UBRELVY, THINPREP 2000 PROCESSOR, Korlym, Wegovy, Ozempic.
Industry payments across TX — which companies pay providers there.
